Molecular and morphological study of SDF-1 in tumor proliferation of pituitary adenoma
SDF-1在垂体腺瘤增殖中的分子及形态学研究
基本信息
- 批准号:20591726
- 负责人:
- 金额:$ 2.91万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2008
- 资助国家:日本
- 起止时间:2008 至 2012
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In the present study, we aimed to develop a novel transfection method for short interference RNA (siRNA) to employ nanotube by the surfactant activity.A6K consisting of six alanine residues and hydrophilic head, lysine, was compared with conventional cationic transfectant reagent, siFECTOR and Lipofectamine 2000. Cyto-toxity for human rat pituitary adenoma cell line, AtT-20 or GH3 was examined with MTS assay. Transfection efficiency was analyzed with FITC-labelled siRNA targeting SDF-1 receptor mRNA with fluorescent activity and microscopy. Ultra-structure of A6K was observed with electron microscopy.Non-cytotoxic level of A6K (IC50, 320.8 ・g/ml) was significantly higher than that of siFECTOR ((IC50, 35.6 ・g/ml) and Lipofectamine 2000 (IC50, 22.4 ・g/ml). Transfection efficiency for the siRNA was elevated in a dose- and time- dependent fashion. Relative expression of SDF-1 and its receptor, CXCR4 and CXCR7 mRNA to ・-actin was reduced in a dose-dependent manner and hypoxia in a real-time RT-PCR study. Ultra-structure of A6K was transformed to micelle formation when siRNA was mixed.Lipid-like self assembling peptide, A6K includes genes in the micelle due to hydrophilic tail. This transfection is a novel and stable method with lower cytotoxity. In conclusion, SDF-1 and its receptor-mediated cell signal pathway is enhanced in hypoxic condition.
在介绍研究中,我们旨在开发一种新型的翻译方法,用于通过基础活动使用纳米管,以纳米管的基础活性。由六个丙氨酸残留物和赖氨酸组成的A6K与常规阳离子阳离子的转化试剂,Sifater和Lipofectamine 2000。 MTS分析。用FITC标记的siRNA靶向具有荧光活性和显微镜的FITC标记的siRNA分析转染效率。用电子显微镜观察到A6K的超结构。非毒性水平的A6K(IC50,320.8 g/ml)显着高于Sifatecter(((IC50,35.6 ・ g/ml)和脂肪触及胺2000(IC50,IC50,IC50,22.4),g/ml-g/ml-g/ml-rippitients。时尚。在实时的RT-PCR研究中,以剂量依赖的方式降低了SDF-1及其受体的表达。稳定的细胞毒性稳定方法,总结为SDF-1及其受体介导的细胞信号途径在低氧条件下增强了。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Clinical clerkship course for medical students on lumbar puncture usingsimulators.
使用模拟器为医学生提供腰椎穿刺临床见习课程。
- DOI:
- 发表时间:2012
- 期刊:
- 影响因子:0
- 作者:Adachi K;Yoshimura A;Aso R;Miyashita T;Yoshida D;Teramoto A;Shimura T.
- 通讯作者:Shimura T.
In celebration of NMC's 50th anniversary.
庆祝 NMC 成立 50 周年。
- DOI:
- 发表时间:2010
- 期刊:
- 影响因子:0
- 作者:Ota T;Kawai K;Kamada K;Kin T;Saito N;川原信隆;高野晋吾;A Teramoto
- 通讯作者:A Teramoto
Intracerebral hemorrhage caused by a neoplastic aneurysm from pleomorphic lung carcinoma.
多形性肺癌肿瘤性动脉瘤引起的脑出血。
- DOI:
- 发表时间:2009
- 期刊:
- 影响因子:0
- 作者:Nomura R;Yoshida D;Kim K;Kobayashi S;Teramoto A.
- 通讯作者:Teramoto A.
A novel transfection method for short interference RNA with lipid-like self-assembling nanotube, A6K
类脂质自组装纳米管A6K转染短干扰RNA的新方法
- DOI:
- 发表时间:2010
- 期刊:
- 影响因子:0
- 作者:D Yoshida;他
- 通讯作者:他
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YOSHIDA Daizo其他文献
YOSHIDA Daizo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YOSHIDA Daizo', 18)}}的其他基金
Molecular aspect of in cell invasion by pituitary adenoma mediated by hypoxia-relating transcription factor
缺氧相关转录因子介导的垂体腺瘤细胞侵袭的分子方面
- 批准号:
17591536 - 财政年份:2005
- 资助金额:
$ 2.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Inhibition of glioma angiogenesis and invasion by anti-microtubule agent in a rat brain tumor model.
在大鼠脑肿瘤模型中抗微管剂抑制神经胶质瘤血管生成和侵袭。
- 批准号:
14571340 - 财政年份:2002
- 资助金额:
$ 2.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Inhibition of Growth on Human Glioma Cells by Estramustiene, Anti-microtubule Agent ; In Vitro Study
抗微管剂雌莫司烯对人胶质瘤细胞生长的抑制作用;
- 批准号:
11671398 - 财政年份:1999
- 资助金额:
$ 2.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Inhibition Of Growth On Human Glioma Cells By Estramustiene Anti-Microtubule Agent ; In Vitro Study
雌莫司烯抗微管剂对人神经胶质瘤细胞生长的抑制;
- 批准号:
07671548 - 财政年份:1995
- 资助金额:
$ 2.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
牙龈卟啉单胞菌激活CAFs调控SDF-1/CXCR4通路促进食管癌进展及免疫逃逸的机制研究
- 批准号:82302966
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
硝酸盐通过SDF-1/CXCR4轴调控EPCs归巢与巨噬细胞串扰减轻糖尿病组织瓣缺血损伤的作用及机制研究
- 批准号:82370925
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
三七总皂苷基于SDF-1/CXCR4信号轴介导骨髓间充质干细胞归巢调控成骨分化及血管再生干预骨质疏松性骨折的研究
- 批准号:82360938
- 批准年份:2023
- 资助金额:32.00 万元
- 项目类别:地区科学基金项目
基于SDF-1/CXCR4轴募集内源性骨髓间充质干细胞探讨电针联合VEGF微球治疗周围神经损伤的机制
- 批准号:82205244
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于外泌体miR-1246介导SDF-1/CXCR4信号通路探讨桂枝芍药知母汤调控RA软骨基质代谢平衡的作用机制
- 批准号:82274390
- 批准年份:2022
- 资助金额:53.00 万元
- 项目类别:面上项目
相似海外基金
Determining the role of the SDF-1/CXCR4 pathway and its intersection with chronic stress to establish novel precision approaches to head and neck cancer management
确定 SDF-1/CXCR4 通路的作用及其与慢性应激的交叉点,以建立头颈癌管理的新型精准方法
- 批准号:
10642091 - 财政年份:2023
- 资助金额:
$ 2.91万 - 项目类别:
エラスターゼ誘導性肺気腫モデルにおける骨髄由来VEGFR1陽性細胞の役割
骨髓来源的 VEGFR1 阳性细胞在弹性蛋白酶诱导的肺气肿模型中的作用
- 批准号:
22K09010 - 财政年份:2022
- 资助金额:
$ 2.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CXCR4/SDF-1 axis ameliorates the impaired wound healing and tissue regeneration in aged periodontal tissue
CXCR4/SDF-1轴改善老化牙周组织中受损的伤口愈合和组织再生
- 批准号:
22K09963 - 财政年份:2022
- 资助金额:
$ 2.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Immunological analysis of the efficacy of SDF-1/CXCR4 inhibitors in idiopathic pulmonary fibrosis
SDF-1/CXCR4抑制剂治疗特发性肺纤维化疗效的免疫学分析
- 批准号:
22K08239 - 财政年份:2022
- 资助金额:
$ 2.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SDF-1 mRNA gene therapy for restoration of erectile function
用于恢复勃起功能的 SDF-1 mRNA 基因治疗
- 批准号:
10325466 - 财政年份:2021
- 资助金额:
$ 2.91万 - 项目类别: